Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypophosphatemia comparison of Monofer versus Ferinject in iron deficiency anemia due to inflammatory bowel disease
2017-002452-87Phase 4Terminated
- Sponsor
- Pharmacosmos
- Start
- Jul 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of ferric derisomaltose, ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Pharmacosmos. Started Jul 2017; status: terminated.
02
Drugs
ferric derisomaltoseferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2017-002452-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002452-87.